BDRX Biodexa Pharmaceuticals PLC: Multiplikator forward rega marang pendapatan

Biodexa Pharmaceuticals (BDRX) focuses on the therapy of rare brain tumors, occupying a niche in neuro-oncology. This forward P/S chart allows for the business valuation to be stripped of market noise, with the 6.40 mark characterizing this parameter. Patented drug delivery systems ensure the company's stability, while the current development stage is dedicated to the commercialization of the portfolio following a series of major mergers.

Biodexa Pharma - Multiplikator Forward P/S BDRX (periode 28.04.2023 - 13.04.2025)

Rincian metrik keuangan lan pasar biodexapharma.com (BDRX)

- rega saiki lan proyeksi nilai saham:

Rega saham Biodexa Pharmaceuticals PLC|BDRX - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Biji pasar BDRX|BDRX - Nilai Bisnis

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Biodexa Pharmaceuticals|BDRX - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih biodexapharma.com|BDRX - Nilai Agregat Aset

- indikator total utang lan likuiditas perusahaan:

Utang marang Ekuitas Biodexa Pharmaceuticals|BDRX - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal Biodexa Pharmaceuticals PLC|BDRX - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku BDRX|BDRX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Biodexa Pharmaceuticals|Likuiditas cepet biodexapharma.com

- rincian asil keuangan lan kelipatan valuasi:

BDRX - Penghasilan resik|Proyeksi bathi mangsa ngarep Biodexa Pharmaceuticals|BDRX - Pangali P/E|Pangali Forward P/E Biodexa Pharmaceuticals PLC|BDRX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA BDRX|BDRX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Biodexa Pharmaceuticals|BDRX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan biodexapharma.com|BDRX - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Biodexa Pharmaceuticals

- data total pendapatan lan volume dodolan:

BDRX - Pendapatan reged perusahaan|Prakiraan volume dodolan Biodexa Pharmaceuticals PLC|BDRX - Kapitalisasi marang pendapatan|Multiplikator Forward P/S BDRX

Ringkesan analisis perusahaan:Biodexa Pharma BDRX

For Biodexa Pharmaceuticals (BDRX), which is developing innovative local therapy methods for brain tumors, the forward P/S history reflects the market valuation of its proprietary drug delivery technologies' potential. This indicator is calculated as the ratio of current market capitalization to projected revenue, allowing investors to assess the extent of expectations priced in and determine the risk of overpaying for the issuer's future commercial success.

Pesaing Biodexa Pharmaceuticals

Multiplikator Forward P/S CVS (CVS Health)|McKesson Corp (MCK) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|COR: Multiplikator forward rega marang pendapatan|CAH (Cardinal Health Group) - Kapitalisasi marang prakiraan pendapatan|HSIC: Multiplikator Forward P/S|prestigebrands.com (PBH) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan WGRX|YI: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan China Jo-Jo Drugstores Inc. (RDGT)|UPC: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S HKPD (Hong Kong Pharma Digital Limited)|Rega forward marang dodolan BIMI|Jiuzhou 360 - Multiplikator Forward P/S|WBA - Multiplikator Forward P/S